Cargando…
The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3
BACKGROUND: It has been proposed that peroxisome proliferator-activated receptor-γ (PPARγ) agonists might reduce renal fibrosis, however, several studies had contradictory results. Moreover, the possible interaction of TGF-β(1), PPARγ, and transcription factors in renal fibrosis have not been invest...
Autores principales: | Németh, Ágnes, Mózes, Miklós M., Calvier, Laurent, Hansmann, Georg, Kökény, Gábor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610924/ https://www.ncbi.nlm.nih.gov/pubmed/31277592 http://dx.doi.org/10.1186/s12882-019-1431-x |
Ejemplares similares
-
PPARγ and TGFβ—Major Regulators of Metabolism, Inflammation, and Fibrosis in the Lungs and Kidneys
por: Kökény, Gábor, et al.
Publicado: (2021) -
Pioglitazone Protects Tubular Epithelial Cells during Kidney Fibrosis by Attenuating miRNA Dysregulation and Autophagy Dysfunction Induced by TGF-β
por: Manzéger, Anna, et al.
Publicado: (2023) -
Sustained hyperosmolarity increses TGF-ß1 and Egr-1 expression in the rat renal medulla
por: Mózes, Miklós M., et al.
Publicado: (2017) -
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009) -
The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
por: Swanson, Christine R, et al.
Publicado: (2011)